Thymoquinone treatment modulates the Nrf2/HO-1 signaling pathway and abrogates the inflammatory response in an animal model of lung fibrosis

References

• El–Medany A, Hagar HH, Moursi M, et al. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur J Pharmacol. 2005;509(1):61–70. doi:10.1016/j.ejphar.2004.12.001.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis K, et al. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. IJERPH.. 2013;10(9):3886–3907. doi:10.3390/ijerph10093886.
   Web of Science ®Google Scholar
• Tao F, Gonzalez-Flecha B, Kobzik L. Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radical Biol Med. 2003;35(4):327–340. doi:10.1016/S0891-5849(03)00280-6.
   PubMed Web of Science ®Google Scholar
• Blum RH, Carter SK, Agre K. A clinical review of bleomycin–a new antineoplastic agent. Cancer. 1973;31(4):903–914. doi:10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N.
   PubMed Web of Science ®Google Scholar
• Coker R, Laurent G. Pulmonary fibrosis: cytokines in the balance. Eur Resp J. 1998;11(6):1218–1221. doi:10.1183/09031936.98.11061218.
   PubMed Web of Science ®Google Scholar
• Atzori L, Chua F, Dunsmore S, et al. Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2, 4-bisethylene glycol. Thorax. 2004;59(3):217–223. doi:10.1136/thx.2003.008979.
   PubMed Web of Science ®Google Scholar
• Wang Q, Giri SN, Hyde DM, et al. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol. 1991;42(5):1115–1122. doi:10.1016/0006-2952(91)90296-H.
   PubMed Web of Science ®Google Scholar
• Filderman AE, Genovese LA, Lazo JS. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochem Pharmacol. 1988;37(6):1111–1116. doi:10.1016/0006-2952(88)90518-7.
   PubMed Web of Science ®Google Scholar
• Galvan L, Huang CH, Prestayko AW, et al. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res. 1981;41(12 Pt 1):5103–5106.
   PubMed Web of Science ®Google Scholar
• Sriram N, Kalayarasan S, Sudhandiran G. Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther. 2009;22(3):221–236. doi:10.1016/j.pupt.2008.12.010.
   PubMed Web of Science ®Google Scholar
• Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299–305. doi:10.1002/ptr.1309.
   PubMed Web of Science ®Google Scholar
• Verma R, Kushwah L, Gohel D, et al. Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in Wistar rats. Pulmonary Med. 2013;2013:1–10. doi:10.1155/2013/921724.
   Google Scholar
• El-Khouly D, El-Bakly WM, Awad AS, et al. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. Toxicology. 2012;302(2–3):106–113. doi:10.1016/j.tox.2012.09.001.
   PubMed Web of Science ®Google Scholar
• Wang HD, Yamaya M, Okinaga S, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med. 2002;165(3):406–411. doi:10.1164/ajrccm.165.3.2003149.
   PubMed Web of Science ®Google Scholar
• Sriram N, Kalayarasan S, Sudhandiran G. Enhancement of antioxidant defense system by epigallocatechin-3-gallate during bleomycin induced experimental pulmonary fibrosis. Biol Pharm Bull. 2008;31(7):1306–1311. doi:10.1248/bpb.31.1306.
   PubMed Web of Science ®Google Scholar
• Towbin H. Origins of protein blotting. Methods Mol Biol. 2009;536:1–3. doi:10.1007/978-1-59745-542-8_1.
   PubMedGoogle Scholar
• Ansari MA, Raish M, Ahmad A, et al. Sinapic acid mitigates gentamicin-induced nephrotoxicity and associated oxidative/nitrosative stress, apoptosis, and inflammation in rats. Life Sci. 2016;165:1–8. doi:10.1016/j.lfs.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Kang MI, Kobayashi A, Wakabayashi N, et al. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. PNAS. 2004;101(7):2046–2051. doi:10.1073/pnas.0308347100.
   PubMed Web of Science ®Google Scholar
• Alam J, Stewart D, Touchard C, et al. Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem. 1999;274(37):26071–26078. doi:10.1074/jbc.274.37.26071.
   PubMed Web of Science ®Google Scholar
• Loboda A, Jazwa A, Grochot-Przeczek A, et al. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signaling. 2008;10(10):1767–1812. doi:10.1089/ars.2008.2043.
   PubMed Web of Science ®Google Scholar
• Pi J, Zhang Q, Woods CG, et al. Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid. Toxicol Appl Pharmacol. 2008;226(3):236–243. doi:10.1016/j.taap.2007.09.016.
   PubMed Web of Science ®Google Scholar
• Yan B, Ma Z, Shi S, et al. Sulforaphane prevents bleomycininduced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2related factor2 activation. Mol Med Reports. 2017;15(6):4005–4014. doi:10.3892/mmr.2017.6546.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu F, Kang L, et al. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium. BMC Pulm Med. 2017;17(1):63. doi:10.1186/s12890-017-0405-7.
   PubMed Web of Science ®Google Scholar
• Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol. 2006;533(1–3):222–239. doi:10.1016/j.ejphar.2005.12.087.
   PubMed Web of Science ®Google Scholar
• Lakari E, Pylkas P, Pietarinen-Runtti P, et al. Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. Hum Pathol. 2001;32(11):1257–1263. doi:10.1053/hupa.2001.28937.
   PubMed Web of Science ®Google Scholar
• Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40(3):362–382. doi:10.1016/j.biocel.2007.08.011.
   PubMed Web of Science ®Google Scholar
• Erden EŞ, Kırkıl G, Deveci F, et al. Ratlarda bleomisin ile oluşturulan akciğer fibrozisinde erdosteinin inflamasyon ve fibrozis üzerine etkileri. Tüberküloz ve Toraks Derg. 2008;56(2):127–138.
   PubMedGoogle Scholar
• Hagiwara S-I, Ishii Y, Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med. 2000;162(1):225–231. doi:10.1164/ajrccm.162.1.9903129.
   PubMed Web of Science ®Google Scholar
• Yildirim Z, Kotuk M, Erdogan H, et al. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res. 2006;40(1):27–33. doi:10.1111/j.1600-079X.2005.00272.x.
   PubMed Web of Science ®Google Scholar
• Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signaling. 2008;10(2):355–370. doi:10.1089/ars.2007.1916.
   PubMed Web of Science ®Google Scholar
• Tarnell EB, Oliver BL, Johnson GM, et al. Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury. Lung. 1992;170(1):41–50. doi:10.1007/BF00164754.
   PubMed Web of Science ®Google Scholar
• Oury TD, Thakker K, Menache M, et al. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol. 2001;25(2):164–169. doi:10.1165/ajrcmb.25.2.4235.
   PubMed Web of Science ®Google Scholar
• Serrano‐Mollar A, Closa D, Prats N, et al. In vivo antioxidant treatment protects against bleomycin‐induced lung damage in rats. Br J Pharmacol. 2003;138(6):1037–1048. doi:10.1038/sj.bjp.0705138.
   PubMed Web of Science ®Google Scholar
• Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008;5(4):e93. doi:10.1371/journal.pmed.0050093.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang X, Chang Q, et al. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol. 2010;627(1–3):304–312. doi:10.1016/j.ejphar.2009.11.007.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Kim H, Liu X, et al. Matrix metalloproteinase-9 activates TGF-beta and stimulates fibroblast contraction of collagen gels. Am J Physiol Lung Cellular Mol Physiol. 2014;306(11):L1006–1015. doi:10.1152/ajplung.00015.2014.
   PubMed Web of Science ®Google Scholar
• Pourgholamhossein F, Sharififar F, Rasooli R, et al. Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation of pro-fibrotic genes and inhibition of oxidative stress. Environ Toxicol Pharmacol. 2016;45:340–345. doi:10.1016/j.etap.2016.06.019.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Choi AM. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signaling. 2002;4(4):625–632. doi:10.1089/15230860260220120.
   PubMed Web of Science ®Google Scholar
• Jiang T, Tian F, Zheng H, et al. Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory response. Kidney Int. 2014;85(2):333–343. doi:10.1038/ki.2013.343.
   PubMed Web of Science ®Google Scholar
• Ganter MT, Roux J, Miyazawa B, et al. Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin-dependent mechanisms. Circ Res. 2008;102(7):804–812. doi:10.1161/CIRCRESAHA.107.161067.
   PubMed Web of Science ®Google Scholar
• Hybertson BM, Lee YM, Cho HG, et al. Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally. Inflammation. 2000;24(4):289–303.
   PubMed Web of Science ®Google Scholar
• Kuwano K, Hagimoto N, Nakanishi Y. The role of apoptosis in pulmonary fibrosis. Histol Histopathol. 2004;19(3):867–881. doi:10.14670/HH-19.867.
   PubMed Web of Science ®Google Scholar
• Mungunsukh O, Griffin AJ, Lee YH, et al. Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. Am J Physiol Lung Cellular Mol Physiol. 2010;298(5):L696–703. doi:10.1152/ajplung.00322.2009.
   PubMed Web of Science ®Google Scholar
• Uhal BD. The role of apoptosis in pulmonary fibrosis. Eur Respiratory Rev. 2008;17(109):138–144. doi:10.1183/09059180.00010906.
   Google Scholar
• Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006;3(4):350–356. doi:10.1513/pats.200601-001TK.
   PubMedGoogle Scholar
• Yang D, Yuan W, Lv C, et al. Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats. Int J Clin Exp Pathol. 2015;8(2):1270–1281.
   PubMed Web of Science ®Google Scholar
• Li M, Li Y, Li J, et al. Long-term effects of TCM Yangqing Kangxian formula on bleomycin-induced pulmonary fibrosis in rats via regulating nuclear factor-kappaB signaling. Evid Based Complement Alternat Med. 2017;2017:1–16. doi:10.1155/2017/2089027.
   Web of Science ®Google Scholar